Clinical Trial of Sipjeondaebo-tang on Fatigue of Breast Cancer Patients

Inclusion Criteria: * men and women aged over 18 years * patients who have histologically or cytologically confirmed breast tumor * patients who applicable AC(doxorubicin + cyclophosphamide) * ECOG score 0 to 2 Exclusion Criteria: * patient impossible to orally intake * patient with dementia, delirium and depression * patient suffering from diseases like chronic hepatitis B, C or hepatocirrhosis * severe liver disability (3-fold the normal high range value for ALT, AST) * patient who has diabetes not controlled by diet, hypertension, hyperthyroidism, * severe systemic disease * use of other investigational products within the past 30 days * hypersensitivity to investigational product * others who are judged not to be appropriate to study